Cargando…
Newly Formed Reticulated Platelets Undermine Pharmacokinetically Short-Lived Antiplatelet Therapies
OBJECTIVE—: Aspirin together with thienopyridine P2Y(12) inhibitors, commonly clopidogrel, is a cornerstone of antiplatelet therapy. However, many patients receiving this therapy display high on-treatment platelet reactivity, which is a major therapeutic hurdle to the prevention of recurrent thrombo...
Autores principales: | Armstrong, Paul C., Hoefer, Thomas, Knowles, Rebecca B., Tucker, Arthur T., Hayman, Melissa A., Ferreira, Plinio M., Chan, Melissa V., Warner, Timothy D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5405774/ https://www.ncbi.nlm.nih.gov/pubmed/28279968 http://dx.doi.org/10.1161/ATVBAHA.116.308763 |
Ejemplares similares
-
P2Y(12) receptor blockade synergizes strongly with nitric oxide and prostacyclin to inhibit platelet activation
por: Chan, Melissa V., et al.
Publicado: (2016) -
Drug-Free Platelets Can Act as Seeds for Aggregate Formation During Antiplatelet Therapy
por: Hoefer, Thomas, et al.
Publicado: (2015) -
Neutrophil-Derived Protein S100A8/A9 Alters the Platelet Proteome in Acute Myocardial Infarction and Is Associated With Changes in Platelet Reactivity
por: Joshi, Abhishek, et al.
Publicado: (2021) -
Clinical significance of measuring reticulated platelets in infectious diseases
por: Liu, Qin-hua, et al.
Publicado: (2017) -
Reticulated Platelets in Medicine: Current Evidence and Further Perspectives
por: Corpataux, Noé, et al.
Publicado: (2020)